Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ANVS | Stock Option (right to buy) | Award | $0 | +26.2K | $0.00 | 26.2K | Nov 17, 2023 | Common Stock | 26.2K | $6.07 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved. |
F2 | The stock option shall vest immediately upon grant date. |